시장보고서

상품코드

1906679

천연 알부민 시장 규모와 예측(2021-2031년) - 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 : 원료별, 용도별, 최종사용자별

Natural Albumin Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Source, Application, and End User

발행일: 2025년 12월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 236 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

당사의 새로운 연구 "천연 알부민 시장 예측(-2031년) - 세계 분석 - 원료별, 용도별, 최종사용자별" 보고서에 따르면 천연 알부민 시장은 2024년 56억 6,000만 달러에서 2031년까지 84억 6,000만 달러로 성장할 이를 것으로 예측되며, 2025-2031년 6.0%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 천연 알부민 시장의 성장 요인으로는 만성 간질환의 저알부민혈증 증가, 집중치료 및 수술 분야에서의 적용 확대, 혈장 분획 기술의 발전, 채혈 인프라의 정비 등을 꼽을 수 있습니다.

천연 알부민은 수용성 단백질이며, 인간 및 동물 혈장 주요 성분입니다.침투압 유지, 호르몬·비타민·약물 운송, 체내 수분 밸런스 조절에 도움이 됩니다.인간 혈청 또는 동물 유래 원료로부터 추출된 순수한 단백질입니다.천연 알부민은 저알부민혈증, 쇼크, 화상, 간질환등의 상태 구명제입니다.면역 반응성이 낮고, 생물학적 적합성이 높고, 생물학적 기능이 강력한 모아 두어 치료, 진단, 세포배양 배지에서 필수적인 존재입니다.그렇지만, 감염 성병원체 전파나 공급 부족이라고 하는 문제로부터, 품질관리 기준을 유지하는 것보다 안전한 재조합 제품 수요로 이동이 진행되고 있습니다.

북미 천연 알부민 시장은 미국, 캐나다, 멕시코로 구분됩니다. 미국 천연 알부민 시장의 성장은 만성 질환 증가와 의료 응용 분야의 발전에 기인합니다. 미국 질병예방통제센터(CDC)에 따르면, 2022년 간질환을 앓고 있는 미국인은 약 450만 명이며, 이 수치는 2024년까지 500만 명 이상으로 증가할 것으로 예측됩니다. 이러한 급증으로 인해 치료 솔루션, 특히 간 관련 질환 관리에 중요한 역할을 하는 인간 혈청 알부민(HSA)에 대한 수요가 증가하고 있습니다. 캐나다 간 재단의 2022-2024 보고서에 따르면, 성인 비알코올성 지방간질환(NAFLD) 유병률은 25%로 추정되며, 저알부민혈증의 위험을 악화시키고 있습니다. 신제품 개발 동향으로는 2023년 캐나다 보건부가 글리볼렉스의 알부틴 20% 제제를 저알부민혈증 치료제로 승인한 것을 들 수 있습니다. 임상시험에서 혈청 알부민 수치가 40% 개선된 것으로 나타났습니다. 캐나다 공중보건청(PHAC)은 2022-2024년 가이드라인에서 난치성 패혈증에 알부민 투여를 권장하고 있으며, 치료받은 환자에서 사망률이 15% 감소하는 효과를 확인했습니다. 이러한 요인에 더해 캐나다의 고령화와 안정적인 혈장 수집 체계가 결합되어 임상 현장에서 천연 알부민에 대한 수요가 지속되고 있습니다. 멕시코의 천연 알부민 시장은 혈장 성분에 대한 수요 증가, 완만하지만 개선되고 있는 기증자 기반, 혈액 수집의 구조적 문제로 인해 형성되고 있습니다. 국립수혈위원회(NBTC)에 따르면, 2023년 멕시코의 헌혈 건수는 160만 건을 기록했습니다.

만성콩팥병(CKD) 유병률 증가로 치료 수요 증가, 미래 시장 기회 제공

만성콩팥병은 여전히 전 세계 보건 문제로 심각한 부담이 되고 있습니다. 국제신장학회의 '세계 신장 건강 아틀라스'에 따르면, 전 세계적으로 약 8억 5,000만 명이 CKD를 앓고 있으며, 이는 전 세계 인구의 약 10%에 해당합니다. "Nephrology Dialysis Transplantation 저널에 게재된 메타분석에 따르면, 2014년부터 2022년까지 전 세계 CKD 유병률은 13.0%이며, 사회경제적, 인구통계학적 격차가 인정되었습니다. 특히 저알부민혈증(혈청 알부민 수치 저하)은 신장 기능 예후 악화와 관련이 있습니다. 2023년 BMC Nephrology에 발표된 코호트 연구에 따르면, 알부민 수치가 약 4.1g/dL 이하로 떨어지면 환자의 추정 사구체여과율(eGFR) 감소 속도가 빨라지고 투석 시작 위험이 높아지는 것으로 나타났습니다. 이는 직접적인 임상적 근거를 뒷받침하는 것입니다. 즉, CKD 유병률 증가는 혈청 단백질 수준을 안정화시키고 진행을 지연시키는 천연 알부민 요법의 혜택을 받을 수 있는 환자가 증가한다는 것을 의미하며, 이는 알부민 제제 제조업체에게 지속적인 기회를 창출합니다.

천연 알부민 시장-주요 시장 역학
시장 성장 촉진요인
- 만성간질환 저알부민혈증 유병률 상승
- 집중 치료 및 외과 수술 응용범위 확대
- 혈장 분획 기술 진보와 채혈 인프라 정비
시장 성장 억제요인
- 고비용과 상환에 관한 과제
- 혈액 매개 병원체 전파 리스크와 공급망 취약성
- 대체 치료법 및 수액 관리 전략 보급
시장 기회
- 만성 신장병(CKD) 유병률 증가가 치료 수요를 촉진
- 투석 환자 영양 불량과 단백질 손실
- 질환 예후 알부민과 바이오마커에 근거한 치료
향후 동향
- 집중 치료 무균 혈장 유래 알부민 선호도 향상
- 저알부민혈증을 수반하는 만성간질환 관리 지속적 사용
- 혈액제제 공급을 위한 혈장 분획 확대
성장 촉진요인과 억제요인의 영향

제6장 천연 알부민 시장-세계 시장 분석

천연 알부민 시장 매출,2021-2031년
천연 알부민 시장 예측 분석

제7장 천연 알부민 시장 분석-유형별

인간 혈청알부민
소 혈청알부민
식물 혈청알부민

제8장 천연 알부민 시장 분석-용도별

치료 용도
약물전달
질병 진단
조사
기타

제9장 천연 알부민 시장 분석-최종사용자별

병원 및 진료소
제약 기업 및 바이오테크놀러지 기업
연구기관
진단실험실
재택치료 환경
기타

제10장 천연 알부민 시장-지역 분석

북미
- 미국
- 캐나다
- 멕시코
유럽
- 독일
- 영국
- 프랑스
- 스페인
- 이탈리아
- 기타 유럽
아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 아시아태평양 기타 국가
중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트
- 기타 중동 및 아프리카
남미 및 중남미
- 브라질
- 아르헨티나
- 기타 남미·중앙아메리카 기타 지역

제11장 경쟁 구도

주요 기업별 히트맵 분석
기업 점유율 분석(2024년)

제12장 업계 상황

시장 이니셔티브
인수합병(M&A)
기타 동향

제13장 기업 개요

CSL Ltd
Grifols SA
Taibang Bio Group Co. Ltd.
Merck KGaA
Octapharma AG
HiMedia Laboratories Pvt Ltd
Takeda Pharmaceutical Co Ltd
Biotest AG.
Sartorius AG
Lee BioSolutions

제14장 부록

LSH 26.01.22

According to our new research study on "Natural Albumin Market Forecast to 2031 -Global Analysis - by Source, Application, and End User," the market is anticipated to grow from US$ 5.66 billion in 2024 to US$ 8.46 billion by 2031; the market is expected to register a CAGR of 6.0% from 2025 to 2031. The natural albumin Market growth is attributed to the increasing hypoalbuminemia in chronic liver diseases, expanding applications in critical care and surgery, advancements in plasma fractionation technologies, and blood collection infrastructure.

Natural albumin is a water-soluble protein and is the major constituent of blood plasma in humans and animals. It helps to maintain oncotic pressure, transport hormones, vitamins, and drugs, and regulate the fluid balance in the body. It is a pure protein extracted from human serum or an animal source. Natural albumin is a rescue agent in conditions such as hypoalbuminemia, shock, burns, and liver diseases. It is minimally immune-reactive, highly biologically compatible, and strongly biologically functional, which makes it indispensable in therapeutics, diagnostics, and cell culture media. However, issues such as infectious agent transmission and supply shortages have prompted a shift in the demand for safer recombinant products that maintain quality control standards.

The natural albumin Market in North America is segmented into the US, Canada, and Mexico. The growth of the US natural albumin Market can be attributed to the rising prevalence of chronic diseases and advancements in medical applications. According to the Centers for Disease Control and Prevention (CDC), liver disease affected approximately 4.5 million Americans in 2022, and this figure is projected to rise to over 5 million by 2024. This surge creates a greater demand for therapeutic solutions, particularly human serum albumin (HSA), which plays a critical role in managing liver-related conditions. The Canadian Liver Foundation estimated NAFLD prevalence at 25% among adults in 2022-2024 reports, exacerbating hypoalbuminemia risks. New product developments include Health Canada's authorization of Grifols' Albutein 20% extension in 2023 for hypoalbuminemia management, improving serum levels by 40% in trials. Other instances encompass PHAC's 2022-2024 guidelines recommending albumin in refractory sepsis, with 15% reduced mortality in treated patients. These factors, combined with Canada's ageing population and stable plasma collection, sustain demand for natural albumin in clinical practice. The natural albumin market in Mexico is shaped by growing demand for plasma components, a slow but improving donor base, and structural challenges in blood collection. In 2023, Mexico recorded 1.6 million blood donations, according to the The National Blood Transfusion Council (NBTC).

Rising Chronic Kidney Disease (CKD) Prevalence Driving Therapeutic Demand to Provide Market Opportunities in Future

CKD remains a major global health burden: according to the International Society of Nephrology's Global Kidney Health Atlas, approximately 850 million people worldwide suffer from CKD, i.e., roughly 10% of the global population. A meta analysis published in Nephrology Dialysis Transplantation found a global CKD prevalence of 13.0% (2014-2022), with socio economic and demographic disparities. Importantly, low serum albumin (hypoalbuminemia) is associated with worse renal outcomes. A 2023 cohort study in BMC Nephrology showed that when albumin falls below ~4.1g/dL, patients have faster eGFR decline and higher risk of dialysis initiation. This underscores a direct clinical rationale: increased CKD prevalence means more patients who might benefit from natural albumin therapy to stabilize serum protein levels and slow progression, creating a sustained opportunity for albumin producers.

World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Center for Biotechnology Information (NCBI), American Chemical Society Publications, The U.S. Centers for Medicare & Medicaid Services (CMS), US Department of Health & Human Services, Public Health Agency of Canada (PHAC), French National Institute of Health and Medical Research (INSERM), Italian National Institute of Health (ISS), The Korean Journal of Internal Medicine, the Saudi Press Agency (SPA), UAE Ministry of Health and Prevention (MOHAP) are among the primary and secondary sources referred to while preparing the natural albumin Market report.

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Natural Albumin Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Natural Albumin Market - Key Market Dynamics

5.1 Natural Albumin Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Hypoalbuminemia in Chronic Liver Diseases
- 5.2.2 Expanding Applications in Critical Care and Surgery
- 5.2.3 Advancing Plasma Fractionation Technologies and Blood Collection Infrastructure
5.3 Market Restraints
- 5.3.1 High Cost and Reimbursement Challenges
- 5.3.2 Risk of Blood-Borne Pathogen Transmission and Supply Chain Vulnerabilities
- 5.3.3 Availability of Alternative Treatments and Fluid Management Strategies
5.4 Market Opportunities
- 5.4.1 Prevalence of Chronic Kidney Diseases (CKD) Drives Therapeutic Demand
- 5.4.2 Malnutrition and Protein Loss in Dialysis Patients
- 5.4.3 Albumin in Disease Prognosis and Biomarker-Guided Therapies
5.5 Future Trends
- 5.5.1 Increased Preference for Pathogen-Free Plasma-Derived Albumin in Critical Care
- 5.5.2 Sustained Use in Chronic Liver Disease Management Amid Hypoalbuminemia
- 5.5.3 Expansion in Plasma Fractionation for Blood Product Supply
5.6 Impact of Drivers and Restraints:

6. Natural Albumin Market - Global Market Analysis

6.1 Natural Albumin Market Revenue (US$ Million), 2021-2031
6.2 Natural Albumin Market Forecast Analysis

7. Natural Albumin Market Analysis - by Type

7.1 Human Serum Albumin
- 7.1.1 Overview
- 7.1.2 Human Serum Albumin: Natural Albumin Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Bovine Serum Albumin
- 7.2.1 Overview
- 7.2.2 Bovine Serum Albumin: Natural Albumin Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Plant Serum Albumin
- 7.3.1 Overview
- 7.3.2 Plant Serum Albumin: Natural Albumin Market - Revenue and Forecast to 2031 (US$ Million)

8. Natural Albumin Market Analysis - by Application

8.1 Therapeutic Applications
- 8.1.1 Overview
- 8.1.2 Therapeutic Applications: Natural Albumin Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Drug Delivery
- 8.2.1 Overview
- 8.2.2 Drug Delivery: Natural Albumin Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Disease Diagnostics
- 8.3.1 Overview
- 8.3.2 Disease Diagnostics: Natural Albumin Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Research
- 8.4.1 Overview
- 8.4.2 Research: Natural Albumin Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Natural Albumin Market - Revenue and Forecast to 2031 (US$ Million)

9. Natural Albumin Market Analysis - by End User

9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Clinics: Natural Albumin Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical and Biotechnological Companies: Natural Albumin Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Research Institutes
- 9.3.1 Overview
- 9.3.2 Research Institutes: Natural Albumin Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories: Natural Albumin Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Homecare Settings
- 9.5.1 Overview
- 9.5.2 Homecare Settings: Natural Albumin Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Natural Albumin Market - Revenue and Forecast to 2031 (US$ Million)

10. Natural Albumin Market - Geographical Analysis

10.1 North America
- 10.1.1 North America Natural Albumin Market Overview
- 10.1.2 North America: Natural Albumin Market - Revenue, 2021-2031 (US$ Million)
  - 10.1.2.1 North America: Natural Albumin Market - Revenue and Forecast Analysis - by Type
  - 10.1.2.2 North America: Natural Albumin Market - Revenue and Forecast Analysis - by Application
  - 10.1.2.3 North America: Natural Albumin Market - Revenue and Forecast Analysis - by Therapeutic Applications
  - 10.1.2.4 North America: Natural Albumin Market - Revenue and Forecast Analysis - by End User
- 10.1.3 North America: Natural Albumin Market - Revenue and Forecast Analysis - by Country
  - 10.1.3.1 United States: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.1.1 United States: Natural Albumin Market Breakdown, by Type
    - 10.1.3.1.2 United States: Natural Albumin Market Breakdown, by Application
    - 10.1.3.1.3 United States: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.1.3.1.4 United States: Natural Albumin Market Breakdown, by End User
  - 10.1.3.2 Canada: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.2.1 Canada: Natural Albumin Market Breakdown, by Type
    - 10.1.3.2.2 Canada: Natural Albumin Market Breakdown, by Application
    - 10.1.3.2.3 Canada: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.1.3.2.4 Canada: Natural Albumin Market Breakdown, by End User
  - 10.1.3.3 Mexico: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.3.1 Mexico: Natural Albumin Market Breakdown, by Type
    - 10.1.3.3.2 Mexico: Natural Albumin Market Breakdown, by Application
    - 10.1.3.3.3 Mexico: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.1.3.3.4 Mexico: Natural Albumin Market Breakdown, by End User
10.2 Europe
- 10.2.1 Europe Natural Albumin Market Overview
- 10.2.2 Europe: Natural Albumin Market - Revenue, 2021-2031 (US$ Million)
  - 10.2.2.1 Europe: Natural Albumin Market - Revenue and Forecast Analysis - by Type
  - 10.2.2.2 Europe: Natural Albumin Market - Revenue and Forecast Analysis - by Application
  - 10.2.2.3 Europe: Natural Albumin Market - Revenue and Forecast Analysis - by Therapeutic Applications
  - 10.2.2.4 Europe: Natural Albumin Market - Revenue and Forecast Analysis - by End User
- 10.2.3 Europe: Natural Albumin Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.1 Germany: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.1.1 Germany: Natural Albumin Market Breakdown, by Type
    - 10.2.3.1.2 Germany: Natural Albumin Market Breakdown, by Application
    - 10.2.3.1.3 Germany: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.2.3.1.4 Germany: Natural Albumin Market Breakdown, by End User
  - 10.2.3.2 United Kingdom: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.2.1 United Kingdom: Natural Albumin Market Breakdown, by Type
    - 10.2.3.2.2 United Kingdom: Natural Albumin Market Breakdown, by Application
    - 10.2.3.2.3 United Kingdom: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.2.3.2.4 United Kingdom: Natural Albumin Market Breakdown, by End User
  - 10.2.3.3 France: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.3.1 France: Natural Albumin Market Breakdown, by Type
    - 10.2.3.3.2 France: Natural Albumin Market Breakdown, by Application
    - 10.2.3.3.3 France: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.2.3.3.4 France: Natural Albumin Market Breakdown, by End User
  - 10.2.3.4 Spain: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.4.1 Spain: Natural Albumin Market Breakdown, by Type
    - 10.2.3.4.2 Spain: Natural Albumin Market Breakdown, by Application
    - 10.2.3.4.3 Spain: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.2.3.4.4 Spain: Natural Albumin Market Breakdown, by End User
  - 10.2.3.5 Italy: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.5.1 Italy: Natural Albumin Market Breakdown, by Type
    - 10.2.3.5.2 Italy: Natural Albumin Market Breakdown, by Application
    - 10.2.3.5.3 Italy: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.2.3.5.4 Italy: Natural Albumin Market Breakdown, by End User
  - 10.2.3.6 Rest of Europe: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.6.1 Rest of Europe: Natural Albumin Market Breakdown, by Type
    - 10.2.3.6.2 Rest of Europe: Natural Albumin Market Breakdown, by Application
    - 10.2.3.6.3 Rest of Europe: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.2.3.6.4 Rest of Europe: Natural Albumin Market Breakdown, by End User
10.3 Asia Pacific
- 10.3.1 Asia Pacific Natural Albumin Market Overview
- 10.3.2 Asia Pacific: Natural Albumin Market - Revenue, 2021-2031 (US$ Million)
  - 10.3.2.1 Asia Pacific: Natural Albumin Market - Revenue and Forecast Analysis - by Type
  - 10.3.2.2 Asia Pacific: Natural Albumin Market - Revenue and Forecast Analysis - by Application
  - 10.3.2.3 Asia Pacific: Natural Albumin Market - Revenue and Forecast Analysis - by Therapeutic Applications
  - 10.3.2.4 Asia Pacific: Natural Albumin Market - Revenue and Forecast Analysis - by End User
- 10.3.3 Asia Pacific: Natural Albumin Market - Revenue and Forecast Analysis - by Country
  - 10.3.3.1 China: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.1.1 China: Natural Albumin Market Breakdown, by Type
    - 10.3.3.1.2 China: Natural Albumin Market Breakdown, by Application
    - 10.3.3.1.3 China: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.3.3.1.4 China: Natural Albumin Market Breakdown, by End User
  - 10.3.3.2 Japan: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.2.1 Japan: Natural Albumin Market Breakdown, by Type
    - 10.3.3.2.2 Japan: Natural Albumin Market Breakdown, by Application
    - 10.3.3.2.3 Japan: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.3.3.2.4 Japan: Natural Albumin Market Breakdown, by End User
  - 10.3.3.3 India: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.3.1 India: Natural Albumin Market Breakdown, by Type
    - 10.3.3.3.2 India: Natural Albumin Market Breakdown, by Application
    - 10.3.3.3.3 India: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.3.3.3.4 India: Natural Albumin Market Breakdown, by End User
  - 10.3.3.4 Australia: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.4.1 Australia: Natural Albumin Market Breakdown, by Type
    - 10.3.3.4.2 Australia: Natural Albumin Market Breakdown, by Application
    - 10.3.3.4.3 Australia: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.3.3.4.4 Australia: Natural Albumin Market Breakdown, by End User
  - 10.3.3.5 South Korea: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.5.1 South Korea: Natural Albumin Market Breakdown, by Type
    - 10.3.3.5.2 South Korea: Natural Albumin Market Breakdown, by Application
    - 10.3.3.5.3 South Korea: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.3.3.5.4 South Korea: Natural Albumin Market Breakdown, by End User
  - 10.3.3.6 Rest of APAC: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.6.1 Rest of APAC: Natural Albumin Market Breakdown, by Type
    - 10.3.3.6.2 Rest of APAC: Natural Albumin Market Breakdown, by Application
    - 10.3.3.6.3 Rest of APAC: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.3.3.6.4 Rest of APAC: Natural Albumin Market Breakdown, by End User
10.4 Middle East and Africa
- 10.4.1 Middle East and Africa Natural Albumin Market Overview
- 10.4.2 Middle East and Africa: Natural Albumin Market - Revenue, 2021-2031 (US$ Million)
  - 10.4.2.1 Middle East and Africa: Natural Albumin Market - Revenue and Forecast Analysis - by Type
  - 10.4.2.2 Middle East and Africa: Natural Albumin Market - Revenue and Forecast Analysis - by Application
  - 10.4.2.3 Middle East and Africa: Natural Albumin Market - Revenue and Forecast Analysis - by Therapeutic Applications
  - 10.4.2.4 Middle East and Africa: Natural Albumin Market - Revenue and Forecast Analysis - by End User
- 10.4.3 Middle East and Africa: Natural Albumin Market - Revenue and Forecast Analysis - by Country
  - 10.4.3.1 Saudi Arabia: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.1.1 Saudi Arabia: Natural Albumin Market Breakdown, by Type
    - 10.4.3.1.2 Saudi Arabia: Natural Albumin Market Breakdown, by Application
    - 10.4.3.1.3 Saudi Arabia: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.4.3.1.4 Saudi Arabia: Natural Albumin Market Breakdown, by End User
  - 10.4.3.2 South Africa: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.2.1 South Africa: Natural Albumin Market Breakdown, by Type
    - 10.4.3.2.2 South Africa: Natural Albumin Market Breakdown, by Application
    - 10.4.3.2.3 South Africa: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.4.3.2.4 South Africa: Natural Albumin Market Breakdown, by End User
  - 10.4.3.3 United Arab Emirates: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.3.1 United Arab Emirates: Natural Albumin Market Breakdown, by Type
    - 10.4.3.3.2 United Arab Emirates: Natural Albumin Market Breakdown, by Application
    - 10.4.3.3.3 United Arab Emirates: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.4.3.3.4 United Arab Emirates: Natural Albumin Market Breakdown, by End User
  - 10.4.3.4 Rest of Middle East and Africa: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.4.1 Rest of Middle East and Africa: Natural Albumin Market Breakdown, by Type
    - 10.4.3.4.2 Rest of Middle East and Africa: Natural Albumin Market Breakdown, by Application
    - 10.4.3.4.3 Rest of Middle East and Africa: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.4.3.4.4 Rest of Middle East and Africa: Natural Albumin Market Breakdown, by End User
10.5 South and Central America
- 10.5.1 South and Central America Natural Albumin Market Overview
- 10.5.2 South and Central America: Natural Albumin Market - Revenue, 2021-2031 (US$ Million)
  - 10.5.2.1 South and Central America: Natural Albumin Market - Revenue and Forecast Analysis - by Type
  - 10.5.2.2 South and Central America: Natural Albumin Market - Revenue and Forecast Analysis - by Application
  - 10.5.2.3 South and Central America: Natural Albumin Market - Revenue and Forecast Analysis - by Therapeutic Applications
  - 10.5.2.4 South and Central America: Natural Albumin Market - Revenue and Forecast Analysis - by End User
- 10.5.3 South and Central America: Natural Albumin Market - Revenue and Forecast Analysis - by Country
  - 10.5.3.1 Brazil: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.1.1 Brazil: Natural Albumin Market Breakdown, by Type
    - 10.5.3.1.2 Brazil: Natural Albumin Market Breakdown, by Application
    - 10.5.3.1.3 Brazil: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.5.3.1.4 Brazil: Natural Albumin Market Breakdown, by End User
  - 10.5.3.2 Argentina: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.2.1 Argentina: Natural Albumin Market Breakdown, by Type
    - 10.5.3.2.2 Argentina: Natural Albumin Market Breakdown, by Application
    - 10.5.3.2.3 Argentina: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.5.3.2.4 Argentina: Natural Albumin Market Breakdown, by End User
  - 10.5.3.3 Rest of South and Central America: Natural Albumin Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.3.1 Rest of South and Central America: Natural Albumin Market Breakdown, by Type
    - 10.5.3.3.2 Rest of South and Central America: Natural Albumin Market Breakdown, by Application
    - 10.5.3.3.3 Rest of South and Central America: Natural Albumin Market Breakdown, by Therapeutic Applications
    - 10.5.3.3.4 Rest of South and Central America: Natural Albumin Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players
11.2 Company Market Share Analysis, 2024

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Merger and Acquisition
12.4 Other Developments

13. Company Profiles

13.1 CSL Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Grifols SA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Taibang Bio Group Co. Ltd.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Merck KGaA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Octapharma AG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 HiMedia Laboratories Pvt Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Takeda Pharmaceutical Co Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Biotest AG.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Sartorius AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Lee BioSolutions
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 List of Abbreviations